Consortium Bio-Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 28 Year, 4 Days
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 0.70 M
as on 11-12-2024
- Revenue -14.43%
(FY 2017)
- Profit -678.92%
(FY 2017)
- Ebitda 68.83%
(FY 2017)
- Net Worth -32.05%
(FY 2017)
- Total Assets -76.03%
(FY 2017)
About Consortium Bio-Technologies
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.70 M.
Siddhant Bali and Vinay Bali serve as directors at the Company.
- CIN/LLPIN
U24129DL1996PTC083937
- Company No.
083937
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 1996
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Consortium Bio-Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddhant Bali  | Additional Director | 16-May-2023 | Current |
| Vinay Bali | Director | 01-Apr-1998 | Current |
Financial Performance of Consortium Bio-Technologies.
Consortium Bio-Technologies Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 14.43% decrease. The company also saw a substantial fall in profitability, with a 678.92% decrease in profit. The company's net worth observed a substantial decline by a decrease of 32.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Consortium Bio-Technologies?
In 2017, Consortium Bio-Technologies had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Smart Steps Outsourcing & Placement Private LimitedActive 11 years 8 monthsSiddhant Bali and Vinay Bali are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 10 Feb 1998 | ₹0.70 M | Open |
How Many Employees Work at Consortium Bio-Technologies?
Unlock and access historical data on people associated with Consortium Bio-Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Consortium Bio-Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Consortium Bio-Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
